Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity.
about
Sp100 interacts with ETS-1 and stimulates its transcriptional activityComparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKsCDK10/cyclin M is a protein kinase that controls ETS2 degradation and is deficient in STAR syndromeThe many faces of SAMA Plasmodium falciparum transcriptional cyclin-dependent kinase-related kinase with a crucial role in parasite proliferation associates with histone deacetylase activityKnockdown of cyclin-dependent kinase 10 (cdk10) gene impairs neural progenitor survival via modulation of raf1a gene expression.cdc-25.4, a Caenorhabditis elegans Ortholog of cdc25, Is Required for Male Mating BehaviorMeiosis genes in Daphnia pulex and the role of parthenogenesis in genome evolution.Regulation of hormonal therapy resistance by cell cycle machinery.Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells.The novel SAM domain protein Aveugle is required for Raf activation in the Drosophila EGF receptor signaling pathwaySelectivity and potency of cyclin-dependent kinase inhibitors.Phylogenetic analysis of CDK and cyclin proteins in premetazoan lineages.CDK10 functions as a tumor suppressor gene and regulates survivability of biliary tract cancer cellsReview of Ets1 structure, function, and roles in immunityMutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation.Cyclin-dependent kinase inhibitor drugs as potential novel anti-inflammatory and pro-resolution agents.Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment.The CDK inhibitors in cancer research and therapy.Deregulations in the cyclin-dependent kinase-9-related pathway in cancer: implications for drug discovery and development.Highlights of the Latest Advances in Research on CDK Inhibitors.Inhibitors of cyclin-dependent kinases as cancer therapeutics.Flavopiridol induces phosphorylation of AKT in a human glioblastoma cell line, in contrast to siRNA-mediated silencing of Cdk9: Implications for drug design and development.Association of human height-related genetic variants with familial short stature in Han Chinese in Taiwan.The awakening of the CDK10/Cyclin M protein kinase.Ets2 knockdown inhibits tumorigenesis in esophageal squamous cell carcinoma in vivo and in vitro.Cyclin G2 promotes cell cycle arrest in breast cancer cells responding to fulvestrant and metformin and correlates with patient survival.Retention of Core Meiotic Genes Across Diverse Hymenoptera.Oligomerization-dependent association of the SAM domains from Schizosaccharomyces pombe Byr2 and Ste4.Characterization of the near native conformational states of the SAM domain of Ste11 protein by NMR spectroscopy.Structural organization of a Sex-comb-on-midleg/polyhomeotic copolymer.CDK10 Mutations in Humans and Mice Cause Severe Growth Retardation, Spine Malformations, and Developmental Delays.miR-433 accelerates acquired chemoresistance of gallbladder cancer cells by targeting cyclin M.Cell Cycle Regulation in Treatment of Breast Cancer.
P2860
Q24292513-FC81684B-FEC9-4C2E-9C3C-0B46F62C1E22Q24796929-5CCB4D4F-0F07-4598-9819-D09E3B20D121Q28116037-6E6B99AA-4883-4709-A79E-39B89D142BBBQ28253873-25100650-E55F-4DB7-B31C-DA6611E77AAAQ30048904-3EBD7680-90EC-414C-B018-A7285150FB77Q30430136-6AAA4694-0E13-4665-A6B2-6ACB752A4561Q30831282-EC391FEB-2B42-4D74-814F-2A1CB2F8BFE8Q33433256-BF1789EB-D906-49C9-BA2B-775019E644A4Q33635621-B4B4C6F6-DD69-4404-BA0B-261D67DA8EE9Q33645120-98BC2875-C7EA-47ED-8882-7EEBE39C822EQ34565488-ACA78CDE-260C-4779-B710-5C8DC9EF65C3Q34651981-A9B24535-FD40-4020-97CD-1FE39159F962Q35085360-4701D811-A3E9-4B56-A5EA-E044E20D451CQ36642776-69A21F9A-6913-46BE-B06C-EB6DBC9B2068Q36794564-80FEDF00-A414-42B9-8F58-DC7D699D6B8BQ37022218-8B8942ED-42E3-489B-A878-E686605DBE60Q37602210-9D1E1184-983C-4624-9860-AF7065110A60Q37683871-1918CE33-177D-41C8-8B92-8C67B190286CQ37923861-3DA2E55F-CBCF-4729-9CF0-1E7411207D51Q38120534-C25D327B-9431-44D9-A936-A6405DB023D7Q38263222-B8E4E93D-9C17-4B21-9A01-C9C17DD555BFQ39125016-1EFDFA31-3849-4547-9770-B156B1AA224BQ39385318-74DC1833-1131-4B78-818C-063EFE49DF43Q41125775-0F86243A-4028-4E47-B948-1153393540E6Q41472998-2BEFDD64-A671-45D8-8D45-90D519A01F48Q42321606-1FE3E2A4-DF00-4848-A983-6F6E9F2C1C2EQ42345385-05F6D81E-AACD-474B-A06F-B88BC19A3C01Q42695853-E5C1E12A-40DF-4A65-BCCF-9F9110DA682FQ44097439-DAA7C39A-8A2D-4362-BB8D-5D2418E7C6E5Q45713086-7E4238EB-5F50-4E4D-951B-A0BCCA62B4E7Q46307097-56D5F040-FA70-48E0-9169-27DE3737055EQ47833514-7DFBA0AF-BFE7-4754-9396-F0D279EA2FF3Q49409135-4650F3CF-495B-41E7-B755-EE8BDCE3D9EFQ49544319-6055D155-64AE-4678-81DE-2FBA5C32A9BB
P2860
Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity.
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cdk10, a Cdc2-related kinase, ...... its transactivation activity.
@ast
Cdk10, a Cdc2-related kinase, ...... its transactivation activity.
@en
type
label
Cdk10, a Cdc2-related kinase, ...... its transactivation activity.
@ast
Cdk10, a Cdc2-related kinase, ...... its transactivation activity.
@en
prefLabel
Cdk10, a Cdc2-related kinase, ...... its transactivation activity.
@ast
Cdk10, a Cdc2-related kinase, ...... its transactivation activity.
@en
P2860
P356
P1433
P1476
Cdk10, a Cdc2-related kinase, ...... its transactivation activity.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1204295
P407
P577
2001-04-01T00:00:00Z
P5875
P6179
1019975211